Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2008-4-24
pubmed:abstractText
Tryprostatin A is an inhibitor of breast cancer resistance protein, consequently a series of structure-activity studies on the cell cycle inhibitory effects of tryprostatin A analogues as potential antitumor antimitotic agents have been carried out. These analogues were assayed for their growth inhibition properties and their ability to perturb the cell cycle in tsFT210 cells. SAR studies resulted in the identification of the essential structural features required for cytotoxic activity. The absolute configuration L-Tyr-L-pro in the diketopiperazine ring along with the presence of the 6-methoxy substituent on the indole moiety of 1 was shown to be essential for dual inhibition of topoisomerase II and tubulin polymerization. Biological evaluation also indicated the presence of the 2-isoprenyl moiety on the indole scaffold of 1 was essential for potent inhibition of cell proliferation. Substitution of the indole N(a)-H in 1 with various alkyl or aryl groups, incorporation of various L-amino acids into the diketopiperazine ring in place of L-proline, and substitution of the 6-methoxy group in 1 with other functionality provided active analogues. The nature of the substituents present on the indole N(a)-H or the indole C-2 position influenced the mechanism of action of these analogues. Analogues 68 (IC(50)=10 microM) and 67 (IC(50)=19 microM) were 7-fold and 3.5-fold more potent, respectively, than 1 (IC(50)=68 microM) in the inhibition of the growth of tsFT210 cells. Diastereomer-2 of tryprostatin B 8 was a potent inhibitor of the growth of three human carcinoma cell lines: H520 (IC(50)=11.9 microM), MCF-7 (IC(50)=17.0 microM) and PC-3 (IC(50)=11.1 microM) and was equipotent with etoposide, a clinically used anticancer agent. Isothiocyanate analogue 71 and 6-azido analogue 72 were as potent as 1 in the tsFT210 cell proliferation and may be useful tools in labeling BCRP.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-10070941, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-10197041, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-10646850, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-10720143, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-10753804, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-11205902, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-11309344, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-11905655, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-11931609, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-12100141, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-12323060, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-12477055, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-12841783, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-14566821, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-14576842, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-14579240, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15027118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15059881, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15205596, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15548419, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15585622, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-15607361, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-1633159, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-16917002, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-1867954, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-2838820, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-2853964, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-2920809, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-4524638, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-6121582, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-7565634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-8557590, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-8698634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-8698635, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-8984634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9039258, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9043671, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9485024, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9562603, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9766472, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9861027, http://linkedlifedata.com/resource/pubmed/commentcorrection/18321710-9918389
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1464-3391
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4626-51
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
More...